PHARMACEUTICAL COMPOSITIONS

Described herein are compositions that can include Compound 1 or Form J of Compound 1, or a pharmaceutically acceptable salt of the aforementioned compounds. Also, described herein is a method of treating a HCV infection in a subject that can include administering to the subject a composition that i...

Full description

Saved in:
Bibliographic Details
Main Authors SANGHVI, TAPAN, DINEHART, KIRK, RAYMOND
Format Patent
LanguageEnglish
French
Published 04.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Described herein are compositions that can include Compound 1 or Form J of Compound 1, or a pharmaceutically acceptable salt of the aforementioned compounds. Also, described herein is a method of treating a HCV infection in a subject that can include administering to the subject a composition that includes Compound 1 or Form J of Compound 1, or a pharmaceutically acceptable salt of the aforementioned compounds. La présente invention concerne des compositions qui peuvent comprendre un composé 1 ou une forme J du composé 1, ou un sel pharmaceutiquement acceptable des composés mentionnés précédemment. L'invention concerne également une méthode de traitement d'une infection par le VHC d'un sujet qui peut faire appel à l'administration, au sujet, d'une composition qui comprend le composé 1 ou la forme J du composé 1, ou un sel pharmaceutiquement acceptable des composés mentionnés précédemment.
Bibliography:Application Number: WO2014US18863